Successful pneumococcal vaccination

Silver, Lisa
October 2003
GP: General Practitioner;10/20/2003, p43
Pneumococcal disease, which includes pneumonia, bacteraemia and meningitis, is a serious disease. It is an important cause of morbidity and mortality, particularly among the elderly, the young, those with an absent or non-functioning spleen and those with impaired immunity. For the first time this year an immunization program has been introduced by the Great Britain Department of Health. GP will be given incentives with an item-of-service fee of £ 6.80 to immunize all the over-65 on the grounds of age alone. Over the next three years in England and Wales, the policy to immunize will be rolled out.


Related Articles

  • Pneumococcal vaccination campaign. Richards, Sarah // Primary Health Care;Mar2006, Vol. 16 Issue 2, p20 

    The article discusses the campaign "Know about Pneumo," which aims to advise people about pneumococcal disease. It has been recommended that people aged 65 and over should be offered a routine pneumococcal vaccination. The Department of Health in Great Britain has announced the addition of...

  • Cost-Effectiveness of Pneumococcal Vaccination of Older People: A Study in 5 Western European Countries. Ament, A.; Baltussen, R.; Duru, G.; Rigaud-Bully, C.; De Graeve, D.; Örtqvist, A.; Jönsson, B.; Verhaegen, J.; Gaillat, J.; Christie, P.; Cifre, A. Salazar; Vivas, D.; Loiseau, C.; Fedson, D. S. // Clinical Infectious Diseases;8/1/2000, Vol. 31 Issue 2, p444 

    Presents a study which determined the cost effectiveness of pneumococcal vaccination of older people in several Western European countries. Evidence of vaccination effectiveness against invasive pneumococcal disease; Differences in hospitalization costs for invasive pneumococcal disease;...

  • Call to increase child PCV jab uptake.  // Practice Nurse;1/11/2008, Vol. 35 Issue 1, p11 

    The article reports on the decision of Great Britain's Department of Health (DoH) to call for more children to be vaccinated with the pneumococcal conjugate vaccine (PCV). Latest figures from the Health Protection Agency show that only 86% of children have received the PCV vaccine so far,...

  • Pneumococcal vaccine switch.  // GP: General Practitioner;3/5/2010, p16 

    The article reports on an announcement by the British Department of Health (DoH) that in the routine childhood immunization programme only the Prevenar 13 pneumococcal vaccine should be used. It is stated that children will be protected against six additional strains of pneumococcal bacteria...

  • Pneumococcal jab causes rise in novel strains. Liddle, Rachel // GP: General Practitioner;4/27/2007, p1 

    The article reports that the pneumococcal vaccine recently introduced into the child immunization program by the British Department of Health (DoH) can lead to an outbreak of novel strains of the bacteria. Routine vaccination with hep-tavalent pneumococcal conjugate vaccine (PCV7) was introduced...

  • REDUCING PNEUMOCOCCAL DISEASE BURDEN. File Jr., Thomas M. // Today's Geriatric Medicine;Mar/Apr2014, Vol. 7 Issue 2, p34 

    The article discusses how the burden of pneumococcal disease, with clinical manifestations of pneumonia and invasive pneumococcal disease (IPD), including meningitis and bacteremia, can be reduced, particularly in older age groups as IPD remains a leading cause of death in the U.S., as of April...

  • Do your part to stave off STREP. Schweon, Steven J.; Metulis, Terri J. // RN;Oct2005, Vol. 68 Issue 10, p34 

    Discusses the nursing and medical management of pathogen Streptococcus pneumoniae (S. pneumoniae) and its related disease. Diseases caused by S. pneumoniae; Information on pneumococcal polysaccharide vaccine; Symptoms of pneumonia, bacteremia, and meningitis; Precautions to take when a patient...

  • Effect of Pneumococcal Vaccination: A Comparison of Vaccination Rates in Patients with Bacteremic and Nonbacteremic Pneumococcal Pneumonia. Musher, Daniel M.; Rueda-Jaimes, Adriana M.; Graviss, Edward A.; Rodriguez-Barradas, Maria C. // Clinical Infectious Diseases;10/15/2006, Vol. 43 Issue 8, p1004 

    Background. Despite the widespread acceptance of the 23-valent pneumococcal capsular polysaccharide vaccine (PPV), its protective effect continues to be disputed. We describe a novel approach to examine the protective effect of this vaccine. Methods. We recorded the vaccination status of every...

  • Child pneumococcal jabs from September.  // GP: General Practitioner;7/21/2006, p4 

    This article reports that the Department of Health of Great Britain has announced that routine pneumococcal vaccination of children aged under two will be available across England and Wales from September 4, 2006. The addition of pneumococcal vaccination to the childhood immunization schedule...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics